Effect of glioma-associated oncogene 1 on the proliferation of human pancreatic cancer PANC-1 cells

WANG Feng,XU Ling,GUO Chuan-yong,YANG Li-juan,HE Shan-shan,XU Xuan-fu,HUANG Yin-shi,WEI Wei,DAI Wei-qi,SHEN Jie,WANG Xing-peng
DOI: https://doi.org/10.3781/j.issn.1000-7431.2011.05.004
2011-01-01
Tumor
Abstract:Objective: To investigate the effect of glioma-associated oncogene 1 (GLI 1) on the proliferation ability of human pancreatic cancer PANC-1 cells. Methods: The recombinant lentiviral vector of RNA interference (RNAi)-targeting GLI 1 gene was constructed. The pLVTHM-GLI1-shRNA or pLVTHM-GFP lentivirus (as the control) was infected into PANC-1 cells. The expressions of GLI1, bcl-2, bcl-xl and proliferating cell nuclear antigen (PCNA) mRNAs and proteins were detected by real-time fluorescence quantitative-PCR and Western blotting, respectively, and the cell growth was measured by cell count kit-8 (CCK8) assay. Results: The GLI1-shRNA-PANC-1 cells with stable low-expression of GLI1 were successfully established. Compared with GFP-PANC-1 and PANC-1 cells, the expression levels of GLI1 mRNA and protein in GLI1-shRNA-PANC-1 cells were down-regulated by (82.1±3.2)% and (76.7± 2.2)%, respectively (P<0.01), and the expression levels of bcl-2 mRNA and protein were down-regulated (49.7±5.4)% and by (43.5±9.4)%, respectively (P<0.01). There were no obvious changes in expressions of bcl-xl or PCNA mRNA and protein among three groups. The proliferation inhibitory rate of GLI1-shRNA-PANC-1 cells was higher than those in GFP-PANC-1 and PANC-1 cells (P<0.05). Conclusion: GLI1 RNAi can inhibit the proliferation ability of pancreatic cancer PANC-1 cells. This effect may be associated with the down-regulation of bcl-2 expression.
What problem does this paper attempt to address?